THP-COPBLM (pirarubicin, cyclophosphamide, vincristine, prednisone, bleomycin and procarbazine) regimen combined with granulocyte colony-stimulating factor (G-CSF) for non-Hodgkin's lymphoma in elderly patients: A prospective study

Leukemia

Volumn 11, Issue 11, 1997, Pages 1817-1820

  Niitsu, N ^a   Umeda, M ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

Elderly; Granulocyte colony stimulating factor; Non Hodgkin's lymphoma; Pirarubicin

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PIRARUBICIN; PREDNISONE; PROCARBAZINE; VINCRISTINE;

AGED; ANEMIA; ARTICLE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CONSTIPATION; GASTROINTESTINAL SYMPTOM; GERIATRIC PATIENT; HAIR LOSS; HEART ARRHYTHMIA; HEMATURIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LEUKOCYTE COUNT; LEUKOPENIA; LIVER DYSFUNCTION; LUNG DISEASE; NAUSEA; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEINURIA; SKIN MANIFESTATION; STOMATITIS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

EID: 0030724554     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400001     Document Type: Article

References (14)

1. Niitsu N, Umeda M. Biweekly COP-BLAM regimen combined with granulocyte colony-stimulating factor (C-CSF) for intermediate-grade non-Hodgkin's lymphoma. Eur J Haematol 1996; 56: 163-167.
2. Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma. Ann Intern Med 1985; 102: 596-602.
3. The Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas; summary and description of working formulation for clinical usage. Cancer 1982; 49: 2112-2135.
4. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. WHO: Geneva, 1979.
5. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860-1861.
6. Niitsu N, Yamazaki J, Igarashi M, Umeda M, Morishita T. Clinical usefulness of 1231-MIBG myocardial SPECT in patients with adriamycin-induced cardiomyopathy. Nucl Med 1994; 31: 1051-1057.
7. Draft for the Japanese Cancer Chemotherapy Society Criteria for Evaluation of the Efficacy of Solid Cancer Chemotherapy. Nippon Gan Chi Shi 1986; 21: 929-941.
8. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
9. Sonneveld P, Hop W, Mulder AH, Michiels JJ, Blijham G, Lelie J, Raemakers JWM, Nieuwenhuis K, Heul C. Full-dose chemotherapy for non-Hodgkin's lymphoma in elderly. Semin Hematol 1994; 31: 9-12.
10. Niitsu N, Umeda M. Usefulness of COP-BLAM therapy with concomitant G-CSF in elderly patients with non-Hodgkin's lymphoma in comparison with patients not given G-CSF. Jpn J Geriat 1995; 32: 410-415.
11. Doroshow RHM. Effect of anthracyclin anti-biotics on oxygen radical formation in rat heart. Cancer Res 1983; 43: 460-472.
12. 123I-MIBG myocardial SPECT in elderly non-Hodgkin's lymphoma patients treated with COP-BLAM and G-CSF. Jpn J Clin Hematol 1995; 36: 1326-1328.
13. Wakasugi S, Wada A, Hasegawa Y, Nakano S, Shibata N. Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine. J Nucl Med 1992; 33: 208-214.
14. Kitamura K. Therapy of elderly malignant lymphoma. Curr Ther 1995; 13: 756-761 (Japanese).